CALGARY, Alberta, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Crown Point Energy Inc. (TSX-V: CWV) ("Crown Point" or the "Company") is pleased to announce that its board of directors (the "Board") has appointed Dr. Brian Moss as the Interim President and CEO of the Company. Brian has been a director of Crown Point since December 2017 and also served as a director from May 2012 to April 2015. In addition, Brian served as Crown Point's President and CEO from November 2016 to February 2022. Brian will serve in these rol ...

Core Insights - Winnebago Industries, Inc. has been recognized as one of America's Most Responsible Companies by Newsweek for the fourth consecutive year, emphasizing its commitment to corporate responsibility, sustainability, and social impact [1][2]. Corporate Responsibility Recognition - The recognition is based on key performance indicators from corporate social responsibility, sustainability, and corporate citizenship reports, along with an independent survey of U.S. residents [2]. Corporate Responsibility Strategy - Winnebago Industries focuses on four key areas in its corporate responsibility strategy: people, community, planet, and governance. Initiatives include reducing greenhouse gas emissions, promoting inclusivity, supporting local communities through volunteerism and philanthropy, and maintaining strong governance practices [3]. Additional Recognitions - In addition to being named one of "America's Most Responsible Companies," Winnebago Industries was also recognized as one of Newsweek's Most Trustworthy Companies in America, America's Greenest Companies, and America's Greatest Workplaces in Manufacturing for 2025 [4]. Company Overview - Winnebago Industries is a leading North American manufacturer of outdoor lifestyle products, including motorhomes, travel trailers, and powerboats, with a commitment to sustainable innovation and vertical integration [5].

Group 1 - Mesa Laboratories, Inc. will release its financial results for the third quarter of fiscal year 2026 on February 3, 2026, at 8:00 A.M. Eastern Time [1] - Mesa Laboratories is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries [2] - The company provides products and services aimed at ensuring product integrity, increasing patient and worker safety, and improving quality of life globally [2] Group 2 - The press release regarding the financial results will be available to the public [1] - Mesa Laboratories' leadership includes Gary Owens as President and CEO and John Sakys as CFO [3] - For further information, Mesa Laboratories can be contacted at 1-303-987-8000 or through their website [3]

TORONTO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Q-Gold Resources Ltd. (TSXV: QGR; OTCQB: QGLDF; Börse Frankfurt: QX9G) (“QGold” or the “Company”) is pleased to announce the appointment of Jamsheed Mehta to its Board of Directors, effective immediately. Mr. Mehta brings over 35 years of capital markets experience, including a distinguished 31-year tenure at BMO Capital Markets. During his time at BMO, he held several senior leadership roles, including Head of Canadian Equities, Derivatives, and ETFs, culminating ...

VANCOUVER, British Columbia, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE | ASX: ORE | OTCQX: ORZCF) (the “Company” or “Orezone”) is pleased to report shallow, high-grade confirmatory grade control drill results from the P17 Zone at its flagship Bomboré Gold Mine. The P17 Zone is a high-grade hard rock deposit outcropping at surface located at the southern end of the Bomboré mining lease. In addition to several phased oxide pits, which have locally been advanced into the hard rock, t ...

Core Points - Diversified Royalty Corp. has increased its annual dividend from $0.275 per share to $0.285 per share effective December 1, 2025, with a cash dividend of $0.02375 per common share for the period of December 1, 2025, to December 31, 2025 [1] - The dividend will be paid on December 31, 2025, to shareholders of record as of the close of business on December 15, 2025 [1] Company Overview - Diversified Royalty Corp. is a multi-royalty corporation focused on acquiring top-line royalties from well-managed multi-location businesses and franchisors in North America [2] - The company's objective is to acquire predictable, growing royalty streams from a diverse group of businesses and franchisors [2] Current Holdings - DIV currently owns trademarks for several brands including Mr. Lube + Tires, AIR MILES®, Sutton, Mr. Mikes, Nurse Next Door, Oxford Learning Centres, Stratus Building Solutions, BarBurrito, and Cheba Hut [3] - Mr. Lube + Tires is the leading quick lube service business in Canada, while AIR MILES® is Canada's largest coalition loyalty program [3] - Other notable holdings include Sutton, a leading residential real estate brokerage franchisor, and BarBurrito, the largest quick service Mexican restaurant chain in Canada [3] Financial Strategy - The company's strategy is to increase cash flow per share through accretive royalty purchases and the growth of purchased royalties [4] - DIV aims to maintain a predictable and stable monthly dividend to shareholders and increase the dividend over time as cash flow per share allows [4]

Core Insights - Apellis Pharmaceuticals announced positive results from the Phase 3 VALIANT study for EMPAVELI (pegcetacoplan) in treating C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN), rare kidney diseases [1][4] Company Overview - Apellis Pharmaceuticals is a biopharmaceutical company focused on complement science, developing therapies for serious diseases, including the first treatment for C3G and primary IC-MPGN in patients aged 12 and older [25] Study Results - The VALIANT study demonstrated a statistically significant 68% reduction in proteinuria in EMPAVELI-treated patients compared to placebo [7] - EMPAVELI-treated patients showed stabilization of kidney function with a difference of +6.3 mL/min/1.73 m compared to placebo [7] - A majority of EMPAVELI-treated patients achieved zero C3 staining intensity, indicating complete clearance of C3 deposits [7][6] Safety Profile - The VALIANT study reported favorable safety and tolerability for EMPAVELI, with common adverse reactions including infusion site reactions, pyrexia, and nasopharyngitis [3][22] - No cases of meningococcal infection due to encapsulated bacteria were reported across over 2,750 patient-years of experience with EMPAVELI [3] Market Potential - Approximately 50% of patients with C3G and primary IC-MPGN may experience kidney failure within five to ten years of diagnosis, highlighting the urgent need for effective treatments [8] - The diseases are estimated to affect around 5,000 individuals in the U.S. and up to 8,000 in Europe, indicating a significant market opportunity for EMPAVELI [8]

Core Insights - AGF Management Limited reported total assets under management (AUM) and fee-earning assets of $60.4 billion as of November 30, 2025, reflecting a 12.7% year-over-year increase [1][2]. AUM Breakdown - Total Mutual Fund AUM remained stable at $35.0 billion from October to November 2025, up from $30.7 billion in November 2024 [2][4]. - Exchange-traded funds and separately managed accounts increased to $4.1 billion in November 2025 from $3.9 billion in October 2025 and $2.5 billion in November 2024 [2]. - Segregated accounts and sub-advisory assets rose to $7.2 billion in November 2025, consistent with October 2025 and up from $7.0 billion in November 2024 [2]. - AGF Private Wealth AUM increased to $9.5 billion in November 2025 from $9.4 billion in October 2025 and $8.5 billion in November 2024 [2]. AGF Capital Partners - AGF Capital Partners AUM remained stable at $2.5 billion in November 2025, unchanged from October 2025 but down from $2.8 billion in November 2024 [4]. - Fee-earning assets for AGF Capital Partners were reported at $2.1 billion, consistent across the months and year [4]. Mutual Fund AUM by Category - Domestic Equity Funds AUM increased to $4.7 billion in November 2025 from $4.6 billion in October 2025 and remained the same as November 2024 [3]. - U.S. and International Equity Funds AUM slightly decreased to $22.7 billion in November 2025 from $22.8 billion in October 2025, up from $19.0 billion in November 2024 [3]. - Domestic Fixed Income Funds AUM remained stable at $2.3 billion in November 2025, up from $1.8 billion in November 2024 [3]. Company Overview - AGF Management Limited, founded in 1957, is an independent and globally diverse asset management firm with operations in North America and Europe [5][7]. - The firm serves over 815,000 investors and trades on the Toronto Stock Exchange under the symbol AGF.B [7].

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS AGENCIES VANCOUVER, British Columbia, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Infinico Metals Corp. (“Infinico” or the “Company”) (TSX-V: INFM) is pleased to announce a proposed non-brokered private placement financing (the “Offering”) for gross proceeds of up to $200,000 composed of the sale of up to 20,000,000 pre-consolidation shares (“Shares”) at a price of $0.01 per Share. The gross proceeds from the sale of Shares will be used fo ...

RIDGELAND, Miss., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (NASDAQ: CALM), the largest egg company in the United States and a leading player in the egg-based food industry, is strengthening its prepared foods platform through new leadership appointments and targeted prepared foods production capacity expansions. Johnathan Zoeller has joined Cal-Maine Foods as Chief Financial Officer, Prepared Foods, adding valuable external experience with over 25 years as a senior financial and corporate acc ...